Human herpesvirus 1 Injection
- Brand(s)
- Imlygic
- Category(s)
- prescription
- SPL Type(s)
- Human Prescription
- Master SPL
- Amgen Inc (2015-10-29)
- Oldest Current Product
- 2015-11-02
- License(s)
- BLA
- RxNORM
- INJECTION\HUMAN HERPESVIRUS 1
- SPL Active
- INTRALESIONAL\INJECTION, SUSPENSION\TALIMOGENE LAHERPAREPVEC
- SPL Moiety
- INTRALESIONAL\INJECTION, SUSPENSION\TALIMOGENE LAHERPAREPVEC
product(s) by strength(s)
1 ml talimogene laherparepvec 1000000 unt injection
| # | id | brand | category | labeler | first marketed | active ingredient(s) | route | dose form | application | spl |
|---|
| 1 | 555130078 | Imlygic | BLA | Amgen Inc | 2015-11-02 | TALIMOGENE LAHERPAREPVEC | INTRALESIONAL | INJECTION, SUSPENSION | 125518 | 64ffb680-ea8c-42fc-9649-9e8c0eb77ddb |
1 ml talimogene laherparepvec 100000000 unt injection
| # | id | brand | category | labeler | first marketed | active ingredient(s) | route | dose form | application | spl |
|---|
| 1 | 555130079 | Imlygic | BLA | Amgen Inc | 2015-11-02 | TALIMOGENE LAHERPAREPVEC | INTRALESIONAL | INJECTION, SUSPENSION | 125518 | 64ffb680-ea8c-42fc-9649-9e8c0eb77ddb |
| # | id | title | category | type | labeler | last update | version | product(s) |
|---|
| 1 | 64ffb680-ea8c-42fc-9649-9e8c0eb77ddb (view SPL) | These highlights do not include all the information needed to use IMLYGIC TM safely and effectively. See full prescribing information for IMLYGIC . I MLYGIC ( talimogene laherparepvec ) Suspension for intralesional injection Initial U.S. Approval: 2015 | prescription | Human Prescription | Amgen Inc | 2015-10-29 | 4 | 555130078, 555130079 |